Axogen, Inc. — Director's Dealing 2021

Apr 30, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Axogen, Inc. (AXGN)
CIK: 0000805928
Period of Report: 2021-04-28

Reporting Person: DeVinney Erick Wayne (VP of Clin. & Trans. Sciences)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-04-28	Common Stock	M	10000	$2.86	Acquired	78082	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-04-28	Employee Stock Option (right to buy)	$2.86	M	10000	Disposed	2021-05-01	Common Stock (10000.0)	Direct

Footnotes

F1: The Reporting Person has elected to exercise and hold the shares at this time.

F2: All shares pursuant to the employee stock option were fully vested on May 1, 2018 (4 years from the option grant date) based upon a vesting schedule whereby 25% of the aggregate shares vested on May 1, 2015 (12 months from the option grant date) and an additional 12.5% of the aggregate shares each 6 months thereafter.